UK markets close in 2 hours 43 minutes

Anatara Lifesciences Limited (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.14500.0000 (0.00%)
At close: 12:00PM AEDT
Full screen
Previous close0.1450
Open0.1450
Bid0.1500 x 6348300
Ask0.1500 x 5187600
Day's range0.1450 - 0.1450
52-week range0.1400 - 0.2800
Volume105,304
Avg. volume58,909
Market cap10.298M
Beta (5Y monthly)1.06
PE ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings date23 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • ABN Newswire

    Anatara Lifesciences Limited (ANR.AX) Annual Report to Shareholders

    2021 has been a significant year for Anatara Lifesciences Limited (ASX:ANR), as we made steps towards progressing our human health products towards clinical trials, successfully completed animal health studies and progressed licensing discussions.

  • ABN Newswire

    Anatara Lifesciences Limited (ANR.AX) Meet the CEO Investor Webinar

    Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal health in humans and animals, invites shareholders to attend a virtual group briefing with Chief Executive Officer, Steven Lydeamore, on Thursday 9 September 2021 at 11:00am AEST.

  • ABN Newswire

    Anatara Lifesciences Limited (ANR.AX) Investor Presentation

    Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.